Company Overview
Snapshot
Founded in September 2003 by Haggay Tsaban and Amir Ashiri, Verix operates with 51–200 employees. The company has raised $15.45M across two funding rounds from four investors. In June 2023, Verix acquired Start-up.ai, enhancing its capabilities in leveraging AI for life science companies.
Business overview
Verix provides SaaS business intelligence solutions designed to optimize commercial operations, particularly for the life sciences industry. Its core technology integrates external and internal data sources with patented HotSpots technology to offer a comprehensive market view, identifying threats and opportunities. The solutions are available for mobile, web, and offline applications, serving field representatives, account managers, and home office teams. Verix integrates with platforms like Salesforce, Cognos, and SAP to leverage data for critical business insights.
Strategic signal
In November 2025, Verix secured a US patent for its dynamic code technology, which enables intelligent automation within its flagship Tovana platform. This patent signals a significant advancement in the company's proprietary technology, reinforcing its position as a leader in life sciences commercial optimization and potentially expanding its competitive advantage through enhanced AI-driven capabilities.
Log in to access full profile ›Company Intelligence Q&A
- What is Verix's primary focus in the life sciences industry?
- Verix focuses on providing AI/ML-powered platforms that identify patients likely to benefit from specific therapies and the physicians treating them, optimizing commercial efforts for pharmaceutical companies.
- What was a key strategic move made by Verix in June 2023?
- In June 2023, Verix acquired Start-up.ai, a move designed to further enhance its capabilities in leveraging AI to accelerate brand growth for life science companies.
- What patent did Verix secure in November 2025?
- In November 2025, Verix secured a US patent for its dynamic code technology, which enables intelligent automation within its flagship Tovana platform, aimed at life sciences commercial optimization.
- Which companies invested in Verix's B Round funding in February 2006?
- In February 2006, Verix received B Round funding from Hillsven Capital and Viola Ventures.
- What is Verix's approach to optimizing sales and marketing channels for life sciences companies?
- Verix's Omnichannel Optimization solution uses AI and predictive analytics to help life sciences companies optimize their sales and marketing channel mix for improved customer engagement, resource allocation, and sales performance.